Douglas A. Grimm

Client Work

Douglas’ client engagements include:

• Advised a multi-billion dollar global retail company in the establishment of clinical laboratories across the United States.
• Defended a national specialty provider before the Department of Justice, FBI, the Centers for Medicare and Medicaid Services, and the Office of the Inspector General in a False Claims Act investigation that resulted in the government walking away with no fines, penalties, or restitution.
• Represented an integrated health system in a whistleblower proceeding that involved parallel Stark and anti-kickback investigations by CMS and OIG of medical necessity issues.
• Advised a community health system regarding a $180 million acquisition of multiple Ambulatory Surgery Centers (ASCs).
• Advised a large academic medical center on the development and implementation of compliance plans and related procedural requirements.
• Represented a specialty surgical hospital before the Department of Justice in a proceeding charging a hospital contractor with criminal fraud and money laundering, with no adverse consequence to the hospital.
• Represented a community health system before the Office for Civil Rights in a HIPAA breach proceeding involving the medical records of over 100,000 patients with no adverse consequences to the health system.
• Represented an investor-owned chain of nursing homes in its sale to a nonprofit community health system.
• Represented physicians and physician groups in various recovery audit contractor proceedings involving claims in excess of $3 million.

Professional Activities

• Fellow, American College of Healthcare Executives
• Advisory Board Member, Center for Telehealth and e-Health Law
• Member, Healthcare Financial Management Association
• Member, Health Care Compliance Association
• Member, American Health Lawyers Association

Publications, Presentations & Recognitions

Douglas is a frequent author and lecturer on current issues facing health care providers and payors, including trends in fraud and abuse enforcement, HIPAA compliance, and health information technology. He is often quoted in industry publications such as Bloomberg Law and Modern Healthcare. Recent articles and speaking engagements include:

Artificial Intelligence (AI)

• “AI’s Increasing Role In The Health Care Delivery System: Key Legal Considerations,” Healthcare Business Today; August 29, 2023

Telemedicine

• Speaker, “Understanding the Differences to Advance Policy: RPM/RTM is NOT Telehealth or Chronic Care Management,” CTeL Remote Patient Monitoring Summit, October 20, 2022
• Co-Speaker, “Telehealth Reimbursement and Public Policy,” CTeL Digital Health Summit, June 9, 2021
• Moderator, “The State of Telehealth Today: Practical Realities, Public Policy, and the Law,” ArentFox Schiff Webinar, April 28, 2021
• Co-Speaker, “Remote-Patient Monitoring: The New Rule, Scenarios, and Pitfalls to Avoid,” CTeL Digital Health Virtual Summit, December 3, 2020

Transactions/Corporate

• “FTC Hosts ‘Health Check on COPAs: Assessing the Impact of Certificates of Public Advantage in Health Care Markets’,” July 9, 2019
• “Increased Health Care M&A Activity: Representation and Warranty Insurance Coverage,” The Ambulatory M&A Advisor; December 22, 2014
• Speaker, “Unique Partnerships – Structure,” Pennsylvania Institute of Certified Public Accountants; July 2014 (Hershey, PA)

Compliance/Fraud and Abuse

• “A Pebble in the Pond? Potential Ripple of a Court Decision to Vacate the Medicare Part C/D 60-Day Overpayment Rule,” Health Care Counsel; September 17, 2018
• Co-Speaker, “Status of the ACA and Provider Compliance Programs,” National Capital Healthcare Executives (NCHE) Meeting; February 20, 2018 (Arlington, VA)
• Co-Speaker, “The Affordable Care Act: What Now?,” Lawline; June 5, 2017 (Webcast)

HIPAA/Privacy

• Speaker, “Cyber Vulnerabilities: What to Know and What to Do,” Healthcare Group Purchasing Industry Initiative, May 16, 2019
• Co-Panelist, “Health Care Technology 2017: Critical Issues in Cybercare, Digital Medicine, and Structuring Effective Agreements,” PLI Annual Health Care IT Conference; June 13, 2017 (New York, NY)
• Co-Panelist, “Health Care IT 2016: New Technology, New Legal Issues,” PLI Annual Health Care IT Conference; June 3, 2016 (New York, NY)

Reimbursement

• Co-Speaker, “Telehealth Reimbursement and Public Policy,” CTeL Digital Health Summit, June 9, 2021
• Speaker, “HHS’s Provider Relief Fund: What Happens After Today?,” Virginia-DC HFMA Spring Education Virtual Conference, April 15, 2021
• “CMS Releases CY 2020 Proposed Physician Fee Schedule,” Health Care Counsel; August 2, 2019

Research

• FDA, CLIA, or a “Reasonable Combination of Both”: Toward Increased Regulatory Oversight of Genetic Testing, 41 San Francisco L. Rev. 107 (2006), available at https://repository.usfca.edu/usflawreview/vol41/iss2/1
• Informed Consent for All! No Exceptions, 37 New Mexico L. Rev. 39 (2007), available at https://digitalrepository.unm.edu/nmlr/vol37/iss1/4

Life Beyond the Law

Outside of the office, Douglas spends his time with his wife, Milena, and their family. A former member of many bands, Douglas loves music of all kinds and has produced six albums of guitar and techno-based tunes.